Read further: Targeting CA12 to Mitigate Doxorubicin-Induced Cardiotoxicity: Insights from CRISPR...
Author - Hippocrates Briefs Team
VISUALIZED: Discrepancies Between FDA Labeling and Clinical...
Read further: Discrepancies Between FDA Labeling and Clinical Trial Exclusion Criteria for GLP-1...
Discrepancies Between FDA Labeling and Clinical Trial Exclusion...
Article Impact Level: HIGH Data Quality: STRONG Summary of JAMA Internal Medicine. Lily G. Bessette...
Sex Differences in the Impact of VILPA on Cardiovascular Health:...
Article Impact Level: HIGH Data Quality: STRONG Summary of British Journal of Sports Medicine. Dr...
Macroglia-Mediated Waste Clearance and Its Role in...
Article Impact Level: HIGH Data Quality: STRONG Summary of Journal of Comparative Neurology...
Comparing Global Approaches to Drug Price Negotiation: Insights...
Article Impact Level: HIGH Data Quality: STRONG Summary of The Milbank Quarterly, 1468-0009.12714...
Targeting CA12 to Mitigate Doxorubicin-Induced Cardiotoxicity:...
Article Impact Level: HIGH Data Quality: STRONG Summary of Cell Stem Cell. Dr. Chun Liu et al...
Cardiovascular Risks of Menopausal Hormone Therapy: A Study on...
Article Impact Level: HIGH Data Quality: STRONG Summary of BMJ, 387, e078784. Dr. Therese Johansson...
Racial Disparities in Sudden Cardiac Arrest Risk Among Athletes:...
Article Impact Level: HIGH Data Quality: STRONG Summary of The Lancet, 404(10468), 2209–2222...
Impact of Sleep Regularity on Cardiovascular Risk: Findings from...
Article Impact Level: HIGH Data Quality: STRONG Summary of J Epidemiol Community Health. Dr. Jean...